C. Brindley

653 total citations
14 papers, 523 citations indexed

About

C. Brindley is a scholar working on Molecular Biology, Cell Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, C. Brindley has authored 14 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Cell Biology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in C. Brindley's work include Retinoids in leukemia and cellular processes (6 papers), Biotin and Related Studies (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). C. Brindley is often cited by papers focused on Retinoids in leukemia and cellular processes (6 papers), Biotin and Related Studies (3 papers) and Carcinogens and Genotoxicity Assessment (2 papers). C. Brindley collaborates with scholars based in United Kingdom, Switzerland and Netherlands. C. Brindley's co-authors include Jaap Verweij, Ronald Hoekstra, Joachim Drevs, Ferry A.L.M. Eskens, Wim Wynendaele, A.T. van Oosterom, Sebastian Böttcher, Herlinde Dumez, C.E. Orfanos and H. Wokalek and has published in prestigious journals such as British Journal of Cancer, Biochemical Pharmacology and Journal of the American Academy of Dermatology.

In The Last Decade

C. Brindley

14 papers receiving 481 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Brindley United Kingdom 11 322 150 100 83 79 14 523
Michio Maemura Japan 17 205 0.6× 58 0.4× 58 0.6× 48 0.6× 247 3.1× 72 662
Basharut A. Syed United Kingdom 15 250 0.8× 88 0.6× 21 0.2× 22 0.3× 77 1.0× 24 678
Yvonne Sun United States 7 309 1.0× 238 1.6× 11 0.1× 92 1.1× 141 1.8× 7 631
Jeffrey Vacirca United States 9 246 0.8× 79 0.5× 47 0.5× 26 0.3× 353 4.5× 31 744
Miren J. Anasagasti Spain 7 359 1.1× 201 1.3× 55 0.6× 10 0.1× 167 2.1× 8 598
Teresa Carrascal Spain 9 332 1.0× 223 1.5× 41 0.4× 13 0.2× 190 2.4× 9 587
Rabindranath Bera India 12 265 0.8× 62 0.4× 14 0.1× 138 1.7× 79 1.0× 19 619
Diane M. Pierson United States 9 111 0.3× 44 0.3× 24 0.2× 25 0.3× 29 0.4× 11 324
G. Fürstenberger Germany 15 458 1.4× 156 1.0× 27 0.3× 58 0.7× 356 4.5× 27 865
Françoise Gellibert France 8 462 1.4× 33 0.2× 26 0.3× 11 0.1× 157 2.0× 8 730

Countries citing papers authored by C. Brindley

Since Specialization
Citations

This map shows the geographic impact of C. Brindley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Brindley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Brindley more than expected).

Fields of papers citing papers by C. Brindley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Brindley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Brindley. The network helps show where C. Brindley may publish in the future.

Co-authorship network of co-authors of C. Brindley

This figure shows the co-authorship network connecting the top 25 collaborators of C. Brindley. A scholar is included among the top collaborators of C. Brindley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Brindley. C. Brindley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jonge, Maja J.A. de, Stan B. Kaye, Jaap Verweij, et al.. (2004). Phase I and pharmacokinetic study of XR11576, an oral topoisomerase I and II inhibitor, administered on days 1–5 of a 3-weekly cycle in patients with advanced solid tumours. British Journal of Cancer. 91(8). 1459–1465. 15 indexed citations
2.
Eskens, Ferry A.L.M., Herlinde Dumez, Ronald Hoekstra, et al.. (2003). Phase I and pharmacokinetic study of continuous twice weekly intravenous administration of Cilengitide (EMD 121974), a novel inhibitor of the integrins αvβ3 and αvβ5 in patients with advanced solid tumours. European Journal of Cancer. 39(7). 917–926. 178 indexed citations
3.
Brindley, C., et al.. (2000). Clinical Pharmacokinetics of 2???-Deoxy-2???-Methylidenecytidine (DMDC), a Deoxycytidine Analogue Antineoplastic Agent. Clinical Pharmacokinetics. 38(6). 475–491. 7 indexed citations
4.
Brindley, C., Christine Falcoz, Alison E. Mackie, & Alan Bye. (2000). Absorption Kinetics after Inhalation of Fluticasone Propionate via the Diskhaler??, Diskus?? and Metered-Dose Inhaler in Healthy Volunteers. Clinical Pharmacokinetics. 39(Supplement 1). 1–8. 25 indexed citations
5.
Brindley, C., et al.. (1993). Relationship between pharmacokinetics and pharmacodynamics of tinzaparin (logiparin), a low molecular weight heparin, in dogs. Xenobiotica. 23(6). 575–588. 11 indexed citations
6.
Brindley, C.. (1989). Overview of Recent Clinical Pharmacokinetic Studies with Acitretin (Ro 10-1670, Etretin). Dermatology. 178(2). 79–87. 52 indexed citations
7.
Berbis, P., C. Brindley, H. Bun, et al.. (1989). Determination of Acitretin and 13<i>-cis-</i>Acitretin in Skin. Skin Pharmacology and Physiology. 2(4). 181–186. 9 indexed citations
8.
Gollnick, Harald, Robert J. Bauer, C. Brindley, et al.. (1988). Acitretin versus etretinate in psoriasis. Journal of the American Academy of Dermatology. 19(3). 458–468. 102 indexed citations
9.
McNamara, Patrick J., Roxanne C. Jewell, Bradford K. Jensen, & C. Brindley. (1988). Food Increases the Bioavailability of Acitretin. The Journal of Clinical Pharmacology. 28(11). 1051–1055. 46 indexed citations
10.
Geiger, J.-M. & C. Brindley. (1988). <i>Cis-trans</i> Intelconversion of Acitretin in Man. Skin Pharmacology and Physiology. 1(4). 230–236. 10 indexed citations
11.
Bauer, Robert J., C. Brindley, C.E. Orfanos, et al.. (1988). Clinical and pharmacokinetic results of a German multicenter study. 8 indexed citations
12.
Brindley, C., Andreas Gescher, & David Ross. (1983). Studies of the metabolism of dimethylformamide in mice. Chemico-Biological Interactions. 45(3). 387–392. 34 indexed citations
13.
Brindley, C., et al.. (1982). Studies of the pharmacology of N-methylformamide in mice.. PubMed. 66(11). 1957–65. 13 indexed citations
14.
Brindley, C., Andreas Gescher, Simon P. Langdon, et al.. (1982). Studies of the mode of action of antitumour triazenes and triazines—III. Metabolism studies on hexamethylmelamine. Biochemical Pharmacology. 31(5). 625–631. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026